WH
William L Hunter
CEO & PresidentDirector10% Owner

William L Hunter insider trades: Angiotech Pharmaceuticals (ANPI) stock purchases

CEO & President, Angiotech Pharmaceuticals Last trade Nov 20, 2009 28 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2008
4
Companies
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 20, 2009ANPI↑ Buy$22K
Sep 29, 2009ANPI↑ Buy$89K
Sep 29, 2009ANPI↑ Buy$5K
May 5, 2009ANPI↑ Buy$87K
May 4, 2009ANPI↑ Buy$260K
Mar 18, 2009ANPI↑ Buy$29K
Mar 16, 2009ANPI↑ Buy$40K
Dec 23, 2008ANPI↑ Buy$7K
Dec 22, 2008ANPI↑ Buy$155K
Dec 22, 2008ANPI↑ Buy$89K
Dec 22, 2008ANPI↑ Buy$25K
Dec 18, 2008ANPI↑ Buy$65K
Dec 17, 2008ANPI↑ Buy$31K
Dec 15, 2008ANPI↑ Buy$285K
Dec 11, 2008ANPI↑ Buy$112K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William L Hunter's insider trades

William L Hunter is CEO & President at Angiotech Pharmaceuticals (ANPI). Since Dec 11, 2008, William has reported 15 open-market purchases worth $1.3M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.